These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 25445093

  • 1. Autoimmune thyroid disease in Italian patients with non-segmental vitiligo.
    Arunachalam M, Pisaneschi L, Colucci R, Dragoni F, Conti R, Moretti S.
    Eur J Dermatol; 2014; 24(5):625-6. PubMed ID: 25445093
    [No Abstract] [Full Text] [Related]

  • 2. [Anti-thyroid antibodies and autoimmune diseases in patients with vitiligo].
    Peracchi M, Cavagnini F, Ghislanzoni G.
    G Ital Dermatol Minerva Dermatol; 1971 Nov; 46(11):487-91. PubMed ID: 5171287
    [No Abstract] [Full Text] [Related]

  • 3. Vitiligo and polyglandular autoimmune endocrinopathy.
    Bloch MH, Sowers JR.
    Cutis; 1985 Nov; 36(5):417-9, 421. PubMed ID: 4064762
    [Abstract] [Full Text] [Related]

  • 4. High frequency of thyroid dysfunction in patients with vitiligo.
    Hegedüs L, Heidenheim M, Gervil M, Hjalgrim H, Høier-Madsen M.
    Acta Derm Venereol; 1994 Mar; 74(2):120-3. PubMed ID: 7911617
    [Abstract] [Full Text] [Related]

  • 5. Anti-thyroid peroxidase antibody and vitiligo: a controlled study.
    Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM.
    BMC Dermatol; 2006 Mar 10; 6():3. PubMed ID: 16526964
    [Abstract] [Full Text] [Related]

  • 6. Coexistence of bullous pemphigoid, vitiligo, and thyroid disease: a multiple autoimmune syndrome?
    Tirado-Sánchez A, Montes-de-Oca G.
    Dermatol Online J; 2005 Aug 01; 11(2):20. PubMed ID: 16150228
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
    Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A.
    Clin Exp Dermatol; 2006 Sep 01; 31(5):746-9. PubMed ID: 16803462
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases.
    Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, Feliciani C, Tracanna M, Tulli A.
    Eur J Dermatol; 2010 Sep 01; 20(3):354-8. PubMed ID: 20395193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vitiligo, thyroid disease and autoimmunity.
    Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ.
    Br J Dermatol; 1968 Mar 01; 80(3):135-9. PubMed ID: 5646064
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.